{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T20:38:39Z","timestamp":1793911119085,"version":"4.8.0"},"reference-count":120,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.jns.2025.123410","type":"journal-article","created":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T21:25:07Z","timestamp":1738185907000},"page":"123410","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["HIV-associated neurocognitive disorders (HAND): Optimal diagnosis, antiviral therapy, pharmacological treatment, management, and future scopes"],"prefix":"10.1016","volume":"470","author":[{"given":"Krishnendu","family":"Adhikary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arundhati","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riya","family":"Sarkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritam","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumana Roy","family":"Chowdhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishnendu","family":"Ganguly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prithviraj","family":"Karak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"18","key":"10.1016\/j.jns.2025.123410_bb0005","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1212\/01.WNL.0000287431.88658.8b","article-title":"Updated research nosology for HIV-associated neurocognitive disorders","volume":"69","author":"Antinori","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2025.123410_bb0010","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2147\/NBHIV.S30466","article-title":"Management issues in HIV-associated neurocognitive disorders","volume":"2","author":"Cysique","year":"2012","journal-title":"Neurobehav. HIV Med."},{"issue":"6","key":"10.1016\/j.jns.2025.123410_bb0015","first-page":"350","article-title":"Prevalence and pattern of neuropsychological impairment in human immunodeficiency virus-infected\/acquired immunodeficiency syndrome (HIV\/AIDS) patients across pre- and post-highly active antiretroviral therapy eras: a combined study of two cohorts","volume":"10","author":"Cysique","year":"2004","journal-title":"J. Neuro-Oncol."},{"issue":"8","key":"10.1016\/j.jns.2025.123410_bb0020","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1007\/s00415-017-8503-2","article-title":"HIV-1-associated neurocognitive disorder: epidemiology, pathogenesis, diagnosis, and treatment","volume":"264","author":"Eggers","year":"2017","journal-title":"J. Neurol."},{"issue":"12","key":"10.1016\/j.jns.2025.123410_bb0025","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1097\/OLQ.0000000000000719","article-title":"Selecting an HIV test: a narrative review for clinicians and researchers","volume":"44","author":"Hurt","year":"2017","journal-title":"Sex. Transm. Dis."},{"issue":"1","key":"10.1016\/j.jns.2025.123410_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12889-022-14687-4","article-title":"Barriers to vulnerable adolescent girls\u2019 access to sexual and reproductive health","volume":"22","author":"Janighorban","year":"2022","journal-title":"BMC Public Health"},{"key":"10.1016\/j.jns.2025.123410_bb0035","series-title":"Combination HIV Prevention: Tailoring and Coordinating Biomedical, Behavioral and Structural Strategies to Reduce New HIV Infections. Joint United Nations Programme on HIV\/AIDS","author":"Joint United Nations Programme on HIV\/AIDS","year":"2019"},{"key":"10.1016\/j.jns.2025.123410_bb0040","series-title":"The Path that Ends AIDS: UNAIDS Global AIDS Update 2023. Joint United Nations Programme on HIV\/AIDS","author":"Joint United Nations Programme on HIV\/AIDS","year":"2023"},{"issue":"4","key":"10.1016\/j.jns.2025.123410_bb0045","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s11904-013-0176-6","article-title":"Validity of cognitive screens for HIV-associated neurocognitive disorder: a systematic review and an informed screen selection guide","volume":"10","author":"Kamminga","year":"2013","journal-title":"Curr. HIV\/AIDS Rep."},{"issue":"1","key":"10.1016\/j.jns.2025.123410_bb0050","doi-asserted-by":"crossref","first-page":"83","DOI":"10.5334\/aogh.4277","article-title":"Advancing the global fight against HIV\/aids: strategies, barriers, and the road to eradication","volume":"89","author":"Kumah","year":"2023","journal-title":"Ann. Glob. Health"},{"issue":"Suppl. 5","key":"10.1016\/j.jns.2025.123410_bb0055","article-title":"Progress towards 2020 global HIV impact and treatment targets","volume":"24","author":"Mahy","year":"2021","journal-title":"J. Int. AIDS Soc."},{"issue":"4","key":"10.1016\/j.jns.2025.123410_bb0060","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1001\/jama.2012.8538","article-title":"Aging and HIV-related cognitive loss","volume":"308","author":"Mateen","year":"2012","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.jns.2025.123410_bb0065","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1093\/cid\/ciab366","article-title":"Moving on from HAND: why we need new criteria for cognitive impairment in persons living with human immunodeficiency virus and a proposed way forward","volume":"73","author":"Nightingale","year":"2021","journal-title":"Clin. Infect. Dis."},{"issue":"4","key":"10.1016\/j.jns.2025.123410_bb0070","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nrneurol.2016.27","article-title":"HIV-associated neurocognitive disorder--pathogenesis and prospects for treatment","volume":"12","author":"Saylor","year":"2016","journal-title":"Nat. Rev. Neurol."},{"issue":"1","key":"10.1016\/j.jns.2025.123410_bb0075","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006841","article-title":"Origins of HIV and the AIDS pandemic","volume":"1","author":"Sharp","year":"2011","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"1","key":"10.1016\/j.jns.2025.123410_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12889-018-5073-x","article-title":"Theorizing the complexity of HIV disclosure in vulnerable populations: a grounded theory study","volume":"18","author":"Thapa","year":"2018","journal-title":"BMC Public Health"},{"key":"10.1016\/j.jns.2025.123410_bb0085","series-title":"Investment in HIV Cure Research Drops for the First Time in a Decade","author":"The Foundation for AIDS Research","year":"2022"},{"key":"10.1016\/j.jns.2025.123410_bb0090","series-title":"Global AIDS Update. Joint United Nations Programme on HIV\/AIDS","author":"UNAIDS","year":"2022"},{"issue":"15","key":"10.1016\/j.jns.2025.123410_bb0095","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.2147\/IJGM.S295859","article-title":"HIV-associated neurocognitive disorder (HAND): obstacles to early neuropsychological diagnosis","volume":"15","author":"Vastag","year":"2022","journal-title":"Int. J. Gen. Med."},{"issue":"2","key":"10.1016\/j.jns.2025.123410_bb0100","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s11065-009-9102-5","article-title":"Cognitive neuropsychology of HIV-associated neurocognitive disorders","volume":"19","author":"Woods","year":"2009","journal-title":"Neuropsychol. Rev."},{"key":"10.1016\/j.jns.2025.123410_bb0105","series-title":"Antiretroviral Medicines in Low- and Middle-Income Countries: Forecasts of Global and Regional Demand for 2020\u20132024","author":"World Health Organization","year":"2022"},{"key":"10.1016\/j.jns.2025.123410_bb0110","series-title":"Consolidated Guidelines on Person-Centred HIV Patient Monitoring and Case Surveillance","author":"World Health Organization","year":"2017"},{"key":"10.1016\/j.jns.2025.123410_bb0115","series-title":"Guideline on when to Start Antiretroviral Therapy and on Pre-Exposure Prophylaxis for HIV","author":"World Health Organization","year":"2023"},{"key":"10.1016\/j.jns.2025.123410_bb0120","first-page":"136","article-title":"HIV-associated cognitive impairment before and after the advent of combination therapy","volume":"8","author":"Sacktor","year":"2002","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.jns.2025.123410_bb0125","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1212\/WNL.41.6.778","article-title":"Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Report of a working Group of the American Academy of neurology AIDS task force","volume":"41","author":"Janssen","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2025.123410_bb0130","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1212\/01.WNL.0000287431.88658.8b","article-title":"Updated research nosology for HIV-associated neurocognitive disorders","volume":"69","author":"Antinori","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2025.123410_bb0135","first-page":"360","article-title":"Cliniconeuropathologic correlates of human immunodeficiency virus in the era of antiretroviral therapy","volume":"15","author":"Everall","year":"2009","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.jns.2025.123410_bb0140","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1212\/01.wnl.0000225183.74521.72","article-title":"Antiretroviral therapy improves cognitive impairment in HIV+ individuals in sub-Saharan Africa","volume":"67","author":"Sacktor","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2025.123410_bb0145","doi-asserted-by":"crossref","first-page":"828","DOI":"10.7326\/0003-4819-107-6-828","article-title":"Evidence for early central nervous system involvement in the acquired immunodeficiency syndrome (AIDS) and other human immunodeficiency virus (HIV) infections: studies with neuropsychologic testing and magnetic resonance imaging","volume":"107","author":"Grant","year":"1987","journal-title":"Ann. Intern. Med."},{"issue":"14","key":"10.1016\/j.jns.2025.123410_bb0150","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1097\/QAD.0b013e32828e4e27","article-title":"The prevalence and incidence of neurocognitive impairment in the HAART era","volume":"21","author":"Robertson","year":"2007","journal-title":"AIDS"},{"issue":"9","key":"10.1016\/j.jns.2025.123410_bb0155","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1097\/QAD.0b013e3283354a7b","article-title":"Cognitive dysfunction in HIV patients despite long-standing suppression of viremia","volume":"24","author":"Simioni","year":"2010","journal-title":"AIDS"},{"issue":"1","key":"10.1016\/j.jns.2025.123410_bb0160","first-page":"76","article-title":"Neurocognitive impairment and psychiatric comorbidity in well-controlled human immunodeficiency virus-infected Thais from the 2NN cohort study","volume":"16","author":"Pumpradit","year":"2010","journal-title":"J. Neuro-Oncol."},{"issue":"3","key":"10.1016\/j.jns.2025.123410_bb0165","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1365-2796.2004.01388.x","article-title":"Mild cognitive impairment as a diagnostic entity","volume":"256","author":"Petersen","year":"2004","journal-title":"J. Intern. Med."},{"issue":"1","key":"10.1016\/j.jns.2025.123410_bb0170","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s11481-006-9035-1","article-title":"Defining and evaluating HIV-related neurodegenerative disease and its treatment targets: a combinatorial approach to use of cerebrospinal fluid molecular biomarkers","volume":"2","author":"Gisslen","year":"2007","journal-title":"J. NeuroImmune Pharmacol."},{"key":"10.1016\/j.jns.2025.123410_bb0175","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1212\/WNL.0b013e318200d727","article-title":"HIV-associated neurocognitive disorders (HAND) persist in the era of potent antiretroviral therapy: the CHARTER study","volume":"75","author":"Heaton","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2025.123410_bb0180","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1093\/ije\/dyu092","article-title":"Cohort profile: recruitment cohorts in the neuropsychological substudy of the multicenter AIDS cohort study","volume":"44","author":"Becker","year":"2015","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.jns.2025.123410_bb0185","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1212\/WNL.0000000000000492","article-title":"Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline","volume":"82","author":"Grant","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2025.123410_bb0190","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/WCO.0b013e328329cf3c","article-title":"HIV-1 associated dementia: update on pathological mechanisms and therapeutic approaches","volume":"22","author":"Kaul","year":"2009","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.jns.2025.123410_bb0195","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/ana.22053","article-title":"Human immunodeficiency virus-associated neurocognitive disorders: mind the gap","volume":"67","author":"McArthur","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jns.2025.123410_bb0200","first-page":"3","article-title":"HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors","volume":"17","author":"Heaton","year":"2011","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.jns.2025.123410_bb0205","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/S1473-3099(13)70269-X","article-title":"HIV-associated neurocognitive disorder","volume":"13","author":"Clifford","year":"2013","journal-title":"Lancet Infect. Dis."},{"issue":"1","key":"10.1016\/j.jns.2025.123410_bb0210","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/13803390701233865","article-title":"Predictive validity of demographically adjusted normative standards for the HIV dementia scale","volume":"30","author":"Morgan","year":"2008","journal-title":"J. Clin. Exp. Neuropsychol."},{"key":"10.1016\/j.jns.2025.123410_bb0215","first-page":"383","article-title":"Validity of the Montreal cognitive assessment and the HIV dementia scale in the assessment of cognitive impairment in HIV-1 infected patients","volume":"21","author":"Janssen","year":"2015","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.jns.2025.123410_bb0220","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1007\/s00415-010-5883-y","article-title":"Structural gray and white matter changes in patients with HIV","volume":"258","author":"K\u00fcper","year":"2011","journal-title":"J. Neurol."},{"key":"10.1016\/j.jns.2025.123410_bb0225","first-page":"100","article-title":"Relationship of antiretroviral treatment to postmortem brain tissue viral load in human immunodeficiency virus-infected patients","volume":"12","author":"Langford","year":"2006","journal-title":"J. Neuro-Oncol."},{"issue":"3","key":"10.1016\/j.jns.2025.123410_bb0230","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement."},{"issue":"1\u20132","key":"10.1016\/j.jns.2025.123410_bb0235","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jneuroim.2004.08.043","article-title":"Increased frontal white matter diffusion is associated with glial metabolites and psychomotor slowing in HIV","volume":"157","author":"Cloak","year":"2004","journal-title":"J. Neuroimmunol."},{"issue":"2\u20133","key":"10.1016\/j.jns.2025.123410_bb0240","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1159\/000104484","article-title":"Small-vessel vascular disease in human immunodeficiency virus infection: the Hawaii aging with HIV cohort study","volume":"24","author":"McMurtray","year":"2007","journal-title":"Cerebrovasc. Dis."},{"key":"10.1016\/j.jns.2025.123410_bb0245","first-page":"670","article-title":"Highly active antiretroviral therapy for patients with AIDS dementia complex: effect on MR imaging findings and clinical course","volume":"21","author":"Thurnher","year":"2000","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"10.1016\/j.jns.2025.123410_bb0250","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/ene.12006","article-title":"Cognitive impairment in HIV infection is associated with MRI and CSF pattern of neurodegeneration","volume":"20","author":"Steinbrink","year":"2013","journal-title":"Eur. J. Neurol."},{"issue":"04","key":"10.1016\/j.jns.2025.123410_bb0255","first-page":"421","article-title":"Positron emission tomography applications in clinical neurology","volume":"32","author":"Singhal","year":"2012","journal-title":"Semin. Neurol."},{"issue":"2","key":"10.1016\/j.jns.2025.123410_bb0260","doi-asserted-by":"crossref","first-page":"284","DOI":"10.2214\/AJR.10.6332","article-title":"Fdg PET\/CT in patients with hiv","volume":"197","author":"Davison","year":"2011","journal-title":"Am. J. Roentgenol."},{"issue":"4","key":"10.1016\/j.jns.2025.123410_bb0265","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1001\/jama.2009.1064","article-title":"CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment","volume":"302","author":"Mattsson","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.jns.2025.123410_bb0270","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1586\/14789450.2.1.57","article-title":"CSF proteome: a protein repository for potential biomarker identification","volume":"2","author":"Romeo","year":"2005","journal-title":"Expert Rev. Proteomics"},{"key":"10.1016\/j.jns.2025.123410_bb0275","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.parkreldis.2007.02.002","article-title":"CSF biomarker profiles do not differentiate between the cerebellar and parkinsonian phenotypes of multiple system atrophy","volume":"13","author":"Abdo","year":"2007","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.jns.2025.123410_bb0280","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/NEN.0b013e31816a0dc8","article-title":"Apolipoprotein E, amyloid-\u03b2, and blood\u2013brain barrier permeability in Alzheimer disease","volume":"67","author":"Donahue","year":"2008","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.jns.2025.123410_bb0285","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/978-1-60327-210-0_5","article-title":"Proteomics of cerebrospinal fluid: methods for sample processing","volume":"425","author":"Hale","year":"2008","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jns.2025.123410_bb0290","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s11481-006-9035-1","article-title":"Defining and evaluating HIV-related neurodegenerative disease and its treatment targets: a combinatorial approach to use of cerebrospinal fluid molecular biomarkers","volume":"2","author":"Gisslen","year":"2007","journal-title":"J. NeuroImmune Pharmacol."},{"key":"10.1016\/j.jns.2025.123410_bb0295","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3727\/000000007783464731","article-title":"Blood\u2013brain barrier pathology in Alzheimer\u2019s and Parkinson\u2019s disease: implications for drug therapy","volume":"16","author":"Desai","year":"2007","journal-title":"Cell Transplant."},{"key":"10.1016\/j.jns.2025.123410_bb0300","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jneuroim.2007.01.004","article-title":"HIV-1 infected monocyte-derived macrophages affect the human brain microvascular endothelial cell proteome: new insights into blood\u2013brain barrier dysfunction for HIV-1-associated dementia","volume":"185","author":"Ricardo-Dukelow","year":"2007","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jns.2025.123410_bb0305","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1002\/glia.20725","article-title":"Regulation of ABC membrane transporters in glial cells: relevance to the pharmacotherapy of brain HIV-1 infection","volume":"56","author":"Ronaldson","year":"2008","journal-title":"Glia"},{"key":"10.1016\/j.jns.2025.123410_bb0310","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1477-5956-7-8","article-title":"Biomarkers of HIV-1 associated dementia: proteomic investigation of sera","volume":"7","author":"Wiederin","year":"2009","journal-title":"Proteome Sci."},{"key":"10.1016\/j.jns.2025.123410_bb0315","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s11481-006-9025-3","article-title":"Blood\u2013brain barrier: structural components and function under physiologic and pathologic conditions","volume":"1","author":"Persidsky","year":"2006","journal-title":"J. NeuroImmune Pharmacol."},{"issue":"25","key":"10.1016\/j.jns.2025.123410_bb0320","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1056\/NEJMoa1401268","article-title":"Actionable diagnosis of neuroleptospirosis by next-generation sequencing","volume":"70","author":"Wilson","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jns.2025.123410_bb0325","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12941-018-0298-1","article-title":"Metagenomic next-generation sequencing as a diagnostic tool for toxoplasmic encephalitis","volume":"17","author":"Hu","year":"2018","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"issue":"6","key":"10.1016\/j.jns.2025.123410_bb0330","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/mBio.01888-15","article-title":"Making the leap from research laboratory to clinic: challenges and opportunities for next-generation sequencing in infectious disease diagnostics","volume":"6","author":"Goldberg","year":"2015","journal-title":"MBio"},{"issue":"1","key":"10.1016\/j.jns.2025.123410_bb0335","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/clinchem\/hvab173","article-title":"The role of metagenomics and next-generation sequencing in infectious disease diagnosis","volume":"68","author":"Miller","year":"2022","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jns.2025.123410_bb0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2021.117310","article-title":"Value of next-generation sequencing in early diagnosis of patients with tuberculous meningitis","volume":"422","author":"Lin","year":"2021","journal-title":"J. Neurol. Sci."},{"issue":"1","key":"10.1016\/j.jns.2025.123410_bb0345","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJMp1916753","article-title":"Four decades of HIV\/AIDS \u2014 much accomplished, much to do","volume":"383","author":"Fauci","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"23","key":"10.1016\/j.jns.2025.123410_bb0350","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1056\/NEJMp1502020","article-title":"Ending the HIV-AIDS pandemic--follow the science","volume":"373","author":"Fauci","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jns.2025.123410_bb0355","series-title":"Chapter 3 - Health literacy in HIV-associated neurocognitive disorders","first-page":"45","article-title":"HIV-Associated Neurocognitive Disorders","author":"Beltran-Najera","year":"2024"},{"issue":"2","key":"10.1016\/j.jns.2025.123410_bb0360","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2165\/11597770-000000000-00000","article-title":"HIV-associated neurological disorders: a guide to pharmacotherapy","volume":"26","author":"Tan","year":"2012","journal-title":"CNS Drugs"},{"issue":"5","key":"10.1016\/j.jns.2025.123410_bb0365","article-title":"HIV dementia: a bibliometric analysis and brief review of the top 100 cited articles","volume":"14","author":"Hussain","year":"2022","journal-title":"Cureus"},{"issue":"4","key":"10.1016\/j.jns.2025.123410_bb0370","first-page":"1113","article-title":"HIV-associated neurocognitive disorder (HAND) and the Prospect of brain-penetrating protease inhibitors for antiretroviral treatment","volume":"5","author":"Ghosh","year":"2017","journal-title":"Med. Res. Arch."},{"issue":"3","key":"10.1016\/j.jns.2025.123410_bb0375","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1093\/jac\/dkm241","article-title":"Improved survival in HIV-infected persons: consequences and perspectives","volume":"60","author":"Lohse","year":"2007","journal-title":"J. Antimicrob. Chemother."},{"issue":"4","key":"10.1016\/j.jns.2025.123410_bb0380","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1086\/526524","article-title":"Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study","volume":"46","author":"Patel","year":"2008","journal-title":"Clin. Infect. Dis."},{"issue":"14","key":"10.1016\/j.jns.2025.123410_bb0385","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1097\/QAD.0b013e32834a40cd","article-title":"CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy","volume":"25","author":"Ellis","year":"2011","journal-title":"AIDS"},{"issue":"1","key":"10.1016\/j.jns.2025.123410_bb0390","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1186\/s12879-020-05297-9","article-title":"HIV-associated neurocognitive disorder and HIV-associated myelopathy in a patient with a preserved CD4, but high viral load-a rarely reported phenomenon: a case report and literature review","volume":"20","author":"Ayele","year":"2020","journal-title":"BMC Infect. Dis."},{"issue":"3","key":"10.1016\/j.jns.2025.123410_bb0395","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/QAI.0000000000003345","article-title":"Factors associated with antiretroviral adherence among youth living with HIV","volume":"95","author":"Arnold","year":"2024","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"8","key":"10.1016\/j.jns.2025.123410_bb0400","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1097\/QAD.0000000000001778","article-title":"No neurocognitive advantage for immediate antiretroviral treatment in adults with greater than 500 CD4+ T cell counts","volume":"32","author":"Wright","year":"2018","journal-title":"AIDS"},{"issue":"1","key":"10.1016\/j.jns.2025.123410_bb0405","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/infdis\/jix553","article-title":"Structural brain abnormalities in successfully treated HIV infection: associations with disease and cerebrospinal fluid biomarkers","volume":"217","author":"Van Zoest","year":"2018","journal-title":"J. Infect. Dis."},{"issue":"8","key":"10.1016\/j.jns.2025.123410_bb0410","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/QAD.0000000000002219","article-title":"The benefit of immediate compared with deferred antiretroviral therapy on CD4+ cell count recovery in early HIV infection","volume":"33","author":"Sharma","year":"2019","journal-title":"AIDS"},{"issue":"2","key":"10.1016\/j.jns.2025.123410_bb0415","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s11904-010-0042-8","article-title":"HIV, antiretroviral therapies, and the brain","volume":"7","author":"Liner","year":"2010","journal-title":"Curr. HIV\/AIDS Rep."},{"issue":"Suppl. 2","key":"10.1016\/j.jns.2025.123410_bb0420","doi-asserted-by":"crossref","first-page":"S80","DOI":"10.1093\/schbul\/sbr064","article-title":"Thinking about the future cognitive remediation therapy--what works and could we do better?","volume":"37","author":"Wykes","year":"2011","journal-title":"Schizophr. Bull."},{"issue":"2","key":"10.1016\/j.jns.2025.123410_bb0425","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1093\/oxfordjournals.schbul.a007011","article-title":"A review of cognitive training in schizophrenia","volume":"29","author":"Twamley","year":"2003","journal-title":"Schizophr. Bull."},{"issue":"9","key":"10.1016\/j.jns.2025.123410_bb0430","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.4088\/JCP.12m07686","article-title":"Compensatory cognitive training for psychosis: effects in a randomized controlled trial","volume":"73","author":"Twamley","year":"2012","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jns.2025.123410_bb0435","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.neubiorev.2017.02.025","article-title":"The behavioural, cognitive, and neural corollaries of blunted cardiovascular and cortisol reactions to acute psychological stress","volume":"77","author":"Carroll","year":"2017","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"1","key":"10.1016\/j.jns.2025.123410_bb0440","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s40119-020-00209-z","article-title":"Exercise as potential therapeutic target to modulate Alzheimer\u2019s disease pathology in APOE \u03b54 carriers: a systematic review","volume":"10","author":"Tokg\u00f6z","year":"2021","journal-title":"Cardiol. Ther."},{"key":"10.1016\/j.jns.2025.123410_bb0445","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3389\/fneur.2011.00028","article-title":"Exercise-induced cognitive plasticity, implications for mild cognitive impairment and Alzheimer\u2019s disease","volume":"2","author":"Foster","year":"2011","journal-title":"Front. Neurol."},{"issue":"4","key":"10.1016\/j.jns.2025.123410_bb0450","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nrneurol.2016.27","article-title":"HIV-associated neurocognitive disorder \u2014 pathogenesis and prospects for treatment","volume":"12","author":"Saylor","year":"2016","journal-title":"Nat. Rev. Neurol."},{"issue":"1","key":"10.1016\/j.jns.2025.123410_bb0455","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s11065-013-9225-6","article-title":"Cognitive neurorehabilitation of HIV-associated neurocognitive disorders: a qualitative review and call to action","volume":"23","author":"Weber","year":"2013","journal-title":"Neuropsychol. Rev."},{"issue":"10","key":"10.1016\/j.jns.2025.123410_bb0460","doi-asserted-by":"crossref","first-page":"e696","DOI":"10.1016\/S2352-3018(19)30139-0","article-title":"Development and validation of an automated HIV prediction algorithm to identify candidates for pre-exposure prophylaxis: a modelling study","volume":"6","author":"Krakower","year":"2019","journal-title":"Lancet HIV"},{"issue":"2","key":"10.1016\/j.jns.2025.123410_bb0465","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/QAI.0000000000001580","article-title":"Using clinical notes and natural language processing for automated HIV risk assessment","volume":"77","author":"Feller","year":"2018","journal-title":"J. Acquir. Immune DeficSyndr."},{"key":"10.1016\/j.jns.2025.123410_bb0470","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2019.10.016","article-title":"Algorithmic prediction of HIV status using nation-wide electronic registry data","volume":"17","author":"Ahlstrom","year":"2019","journal-title":"EClinicalMedicine"},{"issue":"9","key":"10.1016\/j.jns.2025.123410_bb0475","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1093\/cid\/ciz1096","article-title":"Machine learning to identify persons at high risk of HIV acquisition in rural Kenya and Uganda","volume":"71","author":"Balzer","year":"2019","journal-title":"Clin. Infect. Dis."},{"issue":"6","key":"10.1016\/j.jns.2025.123410_bb0480","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1007\/s11121-019-01019-z","article-title":"Using smartphone survey data and machine learning to identify situational and contextual risk factors for HIV risk behavior among men who have sex with men who are not on PrEP","volume":"20","author":"Wray","year":"2019","journal-title":"Prev. Sci."},{"issue":"Suppl. 2","key":"10.1016\/j.jns.2025.123410_bb0485","doi-asserted-by":"crossref","first-page":"S128","DOI":"10.1097\/QAI.0000000000001240","article-title":"Toward automating HIV identification: machine learning for rapid identification of HIV-related social media data","volume":"74","author":"Young","year":"2017","journal-title":"J. Acquir. Immune DeficSyndr."},{"issue":"6","key":"10.1016\/j.jns.2025.123410_bb0490","first-page":"864","article-title":"Association of age and time of disease with HIV-associated neurocognitive disorders: a Japanese nationwide multicenter study","volume":"23","author":"Kinai","year":"2017","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.jns.2025.123410_bb0495","series-title":"SIGDIAL 2017 Conference; Saarbrucken, Germany","article-title":"SHIHbot: a facebook chatbot for sexual health information on HIV\/AIDS","author":"Brixey","year":"2017"},{"issue":"2","key":"10.1016\/j.jns.2025.123410_bb0500","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41582-024-00927-1","article-title":"Cognitive criteria in HIV: greater consensus is needed","volume":"20","author":"Cysique","year":"2024","journal-title":"Nat. Rev. Neurol."},{"issue":"4","key":"10.1016\/j.jns.2025.123410_bb0505","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1093\/arclin\/acaa076","article-title":"An examination of reliable change methods for measuring cognitive change with the cogstate computerized battery: research and clinical implications","volume":"36","author":"Gates","year":"2021","journal-title":"Arch. Clin. Neuropsychol."},{"issue":"8","key":"10.1016\/j.jns.2025.123410_bb0510","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1080\/13803395.2016.1263282","article-title":"Determining optimal impairment rating methodology for a new HIV-associated neurocognitive disorder screening procedure","volume":"39","author":"Kamminga","year":"2017","journal-title":"J. Clin. Exp. Neuropsychol."},{"issue":"6","key":"10.1016\/j.jns.2025.123410_bb0515","doi-asserted-by":"crossref","first-page":"311","DOI":"10.14336\/AD.2013.0400311","article-title":"Poor aerobic fitness may contribute to cognitive decline in HIV-infected older adults","volume":"4","author":"Mapstone","year":"2013","journal-title":"Aging Dis."},{"issue":"7","key":"10.1016\/j.jns.2025.123410_bb0520","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/s41582-023-00813-2","article-title":"Cognitive impairment in people living with HIV: consensus recommendations for a new approach","volume":"19","author":"Nightingale","year":"2023","journal-title":"Nat. Rev. Neurol."},{"issue":"1","key":"10.1016\/j.jns.2025.123410_bb0525","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s13365-016-0474-z","article-title":"Evaluating the accuracy of self-report for the diagnosis of HIV-associated neurocognitive disorder (HAND): defining \u201csymptomatic\u201d versus \u201casymptomatic\u201d HAND","volume":"23","author":"Obermeit","year":"2017","journal-title":"J. NeuroVirol."},{"issue":"4","key":"10.1016\/j.jns.2025.123410_bb0530","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1212\/WNL.0000000000002277","article-title":"Prevalence of HIV-associated neurocognitive disorders in the Multicenter AIDS Cohort Study","volume":"86","author":"Sacktor","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2025.123410_bb0535","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/641913","article-title":"HIV-associated neurocognitive disorders: the relationship of HIV infection with physical and social comorbidities","author":"Tedaldi","year":"2015","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.jns.2025.123410_bb0540","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101792","article-title":"Meaningful cognitive decline is uncommon in virally suppressed HIV, but sustained impairment, subtle decline and abnormal cognitive aging are not","volume":"56","author":"Aung","year":"2023","journal-title":"eClinicalMedicine"},{"issue":"5","key":"10.1016\/j.jns.2025.123410_bb0545","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/cid\/ciw399","article-title":"A screening strategy for HIV-associated neurocognitive disorders that accurately identifies patients requiring neurological review","volume":"63","author":"Bloch","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jns.2025.123410_bb0550","series-title":"HIV and the Brain: New Challenges in the Modern Era","first-page":"109","article-title":"The assessment of HIV-associated neurocognitive disorders: New challenges in the HAART era","author":"Cysique","year":"2009"},{"issue":"18","key":"10.1016\/j.jns.2025.123410_bb0555","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1212\/01.WNL.0000287431.88658.8b","article-title":"Updated research nosology for HIV-associated neurocognitive disorders","volume":"69","author":"Antinori","year":"2007","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.jns.2025.123410_bb0560","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1515\/jbcpp-2024-0043","article-title":"The underlying causes, treatment options of gut microbiota and food habits in type 2 diabetes mellitus: a narrative review","volume":"35","author":"Adhikary","year":"2024","journal-title":"J. Basic Clin. Physiol. Pharmacol."},{"issue":"1","key":"10.1016\/j.jns.2025.123410_bb0565","doi-asserted-by":"crossref","DOI":"10.1515\/bmc-2022-0042","article-title":"\u03b2-Amyloid peptide modulates peripheral immune responses and neuroinflammation in rats","volume":"15","author":"Adhikary","year":"2024","journal-title":"Biomol. Concepts"},{"key":"10.1016\/j.jns.2025.123410_bb0570","article-title":"Unveiling bisphenol A toxicity: human health impacts and sustainable treatment strategies","author":"Adhikary","year":"2024","journal-title":"Horm. Mol. Biol. Clin. Invest."},{"key":"10.1016\/j.jns.2025.123410_bb0575","article-title":"Progressive approaches in adipose radio imaging: cancer utilization and necessity for advancements","author":"Das","year":"2024","journal-title":"Infect. Disord. Drug Targets"},{"issue":"2","key":"10.1016\/j.jns.2025.123410_bb0580","first-page":"183","article-title":"Nutritional aspects, chemistry profile, extraction techniques of lemongrass essential oil and it\u2019s physiological benefits","volume":"43","author":"Adhikary","year":"2024","journal-title":"J. Am. Nutrit. Assoc."},{"issue":"16","key":"10.1016\/j.jns.2025.123410_bb0585","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e35835","article-title":"Novel targets and improved immunotherapeutic techniques with an emphasis on antimycosal drug resistance for the treatment and management of mycosis","volume":"10","author":"Sarkar","year":"2024","journal-title":"Heliyon"},{"issue":"2","key":"10.1016\/j.jns.2025.123410_bb0590","doi-asserted-by":"crossref","DOI":"10.1016\/j.imj.2024.100112","article-title":"Mucormycosis during COVID-19 era: a retrospective assessment","volume":"3","author":"Mukherjee","year":"2024","journal-title":"Infect. Med."},{"key":"10.1016\/j.jns.2025.123410_bb0595","doi-asserted-by":"crossref","DOI":"10.1016\/j.actatropica.2024.107356","article-title":"Larvicidal activity of \u03b2-Citral: an in-vitro and in-silico study to understand its potential against mosquito","volume":"258","author":"Adhikary","year":"2024","journal-title":"Acta Trop."},{"issue":"Pt3","key":"10.1016\/j.jns.2025.123410_bb0600","article-title":"Biological significance and pathophysiological role of matrix metalloproteinases in the central nervous system","volume":"280","author":"Ganguly","year":"2024","journal-title":"Int. J. Biol. Macromol."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X25000279?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X25000279?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T01:47:25Z","timestamp":1740102445000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X25000279"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":120,"alternative-id":["S0022510X25000279"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2025.123410","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HIV-associated neurocognitive disorders (HAND): Optimal diagnosis, antiviral therapy, pharmacological treatment, management, and future scopes","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2025.123410","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"123410"}}